GOLDMAN SACHS GROUP INC - TRANSCODE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 19 filers reported holding TRANSCODE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,442
-61.5%
13,122
-23.4%
0.00%–
Q4 2022$11,523–17,122–0.00%–
 Download
Other shareholders

There were no reported owners of TRANSCODE THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of TRANSCODE THERAPEUTICS INC shareholders